Get my own profile
Public access
View all12 articles
8 articles
available
not available
Based on funding mandates
Co-authors
- Stefan GrimmeProfessor Universität BonnVerified email at thch.uni-bonn.de
- Andreas HansenAkademischer Oberrat, Mulliken Center for Theoretical Chemistry, University of BonnVerified email at thch.uni-bonn.de
- Christoph BannwarthInstitute of Physical Chemistry; RWTH Aachen UniversityVerified email at rwth-aachen.de
- Sebastian EhlertMicrosoft ResearchVerified email at microsoft.com
- Eike CaldeweyherChemistry Data Tech Lead, AstraZeneca, SwedenVerified email at eikecaldeweyher.de
- Frank NeeseMax Planck Institute für KohlenforschungVerified email at kofo.mpg.de
- Markus BurschPostDoc, Max-Planck-Institut für KohlenforschungVerified email at uni-bonn.de
- Christoph BauerAssociate Principal Scientist, Astra Zeneca, Gothenburg, SwedenVerified email at astrazeneca.com
- Rainer WilckenFlare TherapeuticsVerified email at flaretx.com
- Anikó UdvarhelyiNovartis PharmaVerified email at novartis.com
- Johannes GorgesMulliken Center for Theoretical Chemistry, Bonn, GermanyVerified email at thch.uni-bonn.de
- Patryk Adam WesołowskiUniversity of CambridgeVerified email at cam.ac.uk
- John W R MorganSenior Teaching Associate, University of CambridgeVerified email at cam.ac.uk
- Pit SteinbachInstitute of Physical Chemistry, RWTH Aachen UniversityVerified email at pc.rwth-aachen.de
- Marcel MüllerMulliken Center for Theoretical Chemistry, University of BonnVerified email at thch.uni-bonn.de
- Tim NeudeckerAssistant professor, University of Bremen, GermanyVerified email at uni-bremen.de
- David WalesUniversity of Cambridge
Follow
Philipp Pracht
Feodor Lynen Fellow, Yusuf Hamied Department of Chemistry, University of Cambridge
Verified email at cam.ac.uk